Minimum Investment Rs.1,000:Baroda BNP Paribas Health and Wellness Fund..!
Healthcare
is crucial for human life – its availability and affordability have significant
impact on society's well-being. In developing countries like India, healthcare
services are vital for sustainable economic development.
The Indian
healthcare market, valued at US$ 110 billion in FY16, is projected to reach US$
638 billion by FY25, growing at an average of 22% annually (Indian Brand Equity
Foundation, February 2025). This sector seeks to offer diverse investment
opportunities across the value chain.
Invest
in Baroda BNP Paribas Health and Wellness Fund - designed to tap into the
long-term growth potential of the Pharma and Healthcare sectors.
Healthcare:
A multidecadal theme with multiple growth drivers
Rising Income and Middle-Class Expansion: An ageing population
and growing middle class, with increased purchasing power will increase demand
for quality healthcare services.
Changes in Demographics: The percentage of
population above 45 years of age is projected to rise from 27% in 2023 to 41%
in 2050^. The rise in lifestyle-related illnesses along with ageing population
has increased need for healthcare services. It is estimated that the incidence of
cardiac issues and diabetes would increase by ~34% from 2020 to 2030.
Government Initiatives and Policy
Support:
Various government initiatives aim to provide affordable healthcare to millions
of people, further driving the growth of the sector.
^Source: UN Department of Economic and Social Affairs - World Population Prospects 2024
*Source: Boston Consulting Group Analysis, Report dated 2024
Introducing
Baroda BNP Paribas Health and Wellness Fund
The scheme
seeks to provide investors the opportunity to capitalize on one of the most
resilient and high-growth sectors.
·
Focused
on companies expected to benefit from growth in Pharma and Healthcare space
·
Invest
at least 80% of its net assets in companies in Pharma and Healthcare sector,
and allied service providers to the sector
·
Actively
managed Scheme, with a bottom-up stock selection approach.
·
Best
suited for those looking to hold their investments for over three years to
fully benefit from the sector's growth potential.
·
A
thematic scheme with no market cap limit or preference
Issue Close: 23 June 2025
Type: Open-ended
Category: Equity: Sectoral-Pharma
Minimum Investment (₹):1,000
For more details and investment..!
Personal Finance
Professional
SEBI Registered Mutual Fund Advisor
Phone : 98847 44227
E mail id: yuvarajchakravarthy@gmail.com
Disclaimer: Mutual Fund investments are subject to market risks, read all scheme
related documents carefully. The past performance of the mutual funds is not
necessarily indicative of future performance of the schemes.
.jpg)
